May 26, 2016

HOUSTON, TX--(Marketwired - May 26, 2016) - Nobilis Health Corp. ( NYSE MKT : HLTH ) (TSX: NHC ) ("Nobilis" or the "Company") announced today three independent board nominations for election to its board of directors: Peter Horan, Mike Nichols, and Tom Foster. In addition, existing directors Steve Ozonian, Don Kramer, Jennifer Hauser, and Rich Ganley are standing for re-election to the company's board of directors. Harry Fleming will not stand for reelection but will continue as the Company's Chief Executive Officer. The proposed slate will be presented for election at the company's annual shareholders meeting on June 28, 2016. "After an intensive search and review process, we have recruited an impressive and diverse slate of board nominees to advise the company as we continue to grow," said Mr. Fleming. "Peter Horan is a successful entrepreneur and a pioneer in the digital media space, Mike Nichols is the former chief operating officer and general counsel for Sysco Foods, and Tom Foster is a former Nobilis Board Member and retired international tax attorney from Exxon Mobil," continued Mr. Fleming. "In addition to our immensely qualified new board nominees, the board has taken steps to safeguard shareholder value through the addition of an Advance Notice Policy as described in yesterday's press release," said Steve Ozonian, chairman of the board of Nobilis Health. "The board is committed to protecting shareholders from any predatory takeover actions. We believe that the best way forward is to continue to support management's execution of strategy. " If elected, Nobilis' board of directors will consist of seven members including existing directors Steve Ozonian, Nobilis chairman; Dr. Donald Kramer, Jennifer Hauser, Rich Ganley, and new additions Peter Horan, Mike Nichols, and Thomas Foster. About Nobilis Health Corp. Nobilis ( www.NobilisHealth.com ) is a full-service healthcare development and management company which currently owns or manages four surgical hospitals and five ASCs, partners with thirty-three additional facilities throughout the country, and markets six independent brands. Deploying a unique patient acquisition strategy driven by direct-to-consumer marketing, Nobilis is focused on a specified set of procedures that are performed at our centers by local physicians. Cautionary Statement Regarding Forward-Looking Information This news release contains forward-looking statements (within the meaning of applicable securities laws) and financial outlooks relating to the business of the Company and the environment in which it operates. Forward-looking statements are identified by words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may" and other similar expressions. Some of the forward-looking statements relate to management changes. This risk, and other risks and uncertainties, may cause results to differ materially from those set forth in the forward-looking statements. Additional risks and uncertainties are further discussed in the Company's regulatory filings available on the Company's web site at www.NobilisHealth.com , www.Sedar.com , and www.sec.gov in the risk factors described in the Company's Form 10-K for the fiscal year ended December 31, 2015, filed on March 15, 2016. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. Other than as required by law, the Company undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances. Contact Information